Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer
ClinicalTrials.gov study NCT01283035. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC
ClinicalTrials.gov study NCT00828841. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT02923739. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Ch
ClinicalTrials.gov study NCT01328951. IPD Sharing: Not stated. Countries: 20. Publications: 0.
FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02641639. IPD Sharing: NO. Countries: 3. Publications: 0.
E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT01332266. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT03519230. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression
ClinicalTrials.gov study NCT01230710. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
ClinicalTrials.gov study NCT00849667. IPD Sharing: Not stated. Countries: 30. Publications: 0.
Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT01188876. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02889900. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous No
ClinicalTrials.gov study NCT04716933. IPD Sharing: YES. Countries: 1. Publications: 0.
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT03146663. IPD Sharing: NO. Countries: 2. Publications: 0.
Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT01437488. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy
ClinicalTrials.gov study NCT01859741. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
ClinicalTrials.gov study NCT06040970. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT02608684. IPD Sharing: NO. Countries: 1. Publications: 0.
Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)
ClinicalTrials.gov study NCT02019979. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chem
ClinicalTrials.gov study NCT00283465. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
ClinicalTrials.gov study NCT07214779. IPD Sharing: YES. Countries: 14. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.